Since the FDA’s regulatory policy concluded that there would be no premarket evaluation process for GM products, it has approved variety of GM foods without any labeling requirement. This has led to the increasing consumers’ concern about the overall safety of GMOs. In several protests, Consumers have expressed their concerns about the lack of premarket safety evaluation of GMOs and also called for mandatory GMO labeling, but to no avail. In many occasions, the FDA has declined to address the consumers’ concerns. To date, the FDA has maintained its 1992 GMO policy, explaining that they have resource limitations and other regulatory priorities to address any safety evaluation and labeling issues regarding GM products (Landa, 2014). The FDA has
